Clinical Outcomes between P1 and P0 Lesions for Obscure Gastrointestinal Bleeding with Negative Computed Tomography and Capsule Endoscopy
Authors:
- Young Kyu ChoYCYoung Kyu Cho
- Heesu ParkHPHeesu Park
- Jung Rock MoonJMJung Rock Moon
- Seong Ran JeonSeong Ran Jeon
- Hyun Gun KimHKHyun Gun Kim
- Tae Hee LeeTLTae Hee Lee
- Junseok ParkJPJunseok Park
- Jin-Oh KimJKJin-Oh Kim
- Joon Seong LeeJLJoon Seong Lee
- Hyeon Jeong GoongHGHyeon Jeong Goong
- Bong Min KoBKBong Min Ko
- Suyeon ParkSPSuyeon Park
Open Access
- 6 April 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (4) , 657
Abstract
Background: A simple classification for the relevance of lesions (P0, P1, and P2; no bleeding potential, less likely to bleed, and more likely to bleed, respectively) based on capsule endoscopy (CE) findings has been used. This study aimed at investigating rebleeding rates and predictive factors of P0 and P1 lesions after obtaining negative findings in both, CE and computed tomography (CT), for patients with obscure gastrointestinal bleeding (OGIB). Methods: Among 193 patients resulted in negative CE findings defined as P0 or P1 lesions, 84 patients with negative results on CT images were enrolled in this study. The rebleeding rates and predictive factors were assessed in the P0 and P1 groups. Results: Overall rebleeding rate in patients with negative CT and CE was 17.9%; 18.4% in the P0 group; 17.4% in the P1 group within a median follow-up duration of 18.5 months. In the P0 and P1 groups, the cumulative rebleeding rates were 9.2%, 25.4%, and 25.4%, and 6.9%, 11.8%, and 18.6% at 12, 24, and 60 months, respectively (p = 0.97). There were no independent rebleeding associated factors in the P0 group, whereas Charlson comorbidity index (CCI) (hazard ratio (HR) = 2.019, 95% confidence interval (CI): 1.158–3.519, p = 0.013), and initial low hemoglobin (Hb) level (p = 0.037) were independent predictive factors responsible for rebleeding in the P1 group. Conclusions: Despite having negative findings on CT and CE, patients with OGIB have a significant potential rebleeding risk. Although there was no significant difference in rebleeding rates between the P0 and P1 groups on CE, the P1 group, with CCI or low initial Hb level, should be cautiously observed after the first bleeding episode.Keywords
Funding Information
- the Soonchunhyang University Research Fund (NA)
This publication has 29 references indexed in Scilit:
- Use of small bowel capsule endoscopy in clinical practice: how has it performed?The Korean Journal of Internal Medicine, 2020
- Changes in performance of small bowel capsule endoscopy based on nationwide data from a Korean Capsule Endoscopy RegistryThe Korean Journal of Internal Medicine, 2020
- Clinical Practice Guideline for EnteroscopyDigestive Endoscopy, 2017
- Quality Indicators for Small Bowel Capsule EndoscopyClinical Endoscopy, 2017
- Current status and future perspectives of capsule endoscopyIntestinal Research, 2016
- ACG Clinical Guideline: Diagnosis and Management of Small Bowel BleedingAmerican Journal of Gastroenterology, 2015
- Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical GuidelineEndoscopy, 2015
- Long-term outcome of capsule endoscopy in obscure gastrointestinal bleeding: a nationwide analysisEndoscopy, 2013
- Guideline for Capsule Endoscopy: Obscure Gastrointestinal BleedingClinical Endoscopy, 2013
- Negative capsule endoscopy without subsequent enteroscopy does not predict lower long-term rebleeding rates in patients with obscure GI bleedingGastrointestinal Endoscopy, 2010